IL13 and Hyperglycemia: In the absence of IL-13, the postprandial hepatic glucose metabolism was disrupted, and the glucose uptake in the white adipose tissues was reduced, resulting in insulin resistance, postprandial hyperglycemia, weight gain, decreased oxygen consumption, and increased triglyceride levels in the blood and liver [92].